Improving life for women through cancer research

ANZGOG would like to acknowledge the following corporate supporters and professional services we receive.
Holman Webb for their legal services assisting ANZGOG operations. 
 Caledonian Clinical TrainingThank you to Eleanor Allan from Caledonian Clinical Training for providing outstanding Professional & GCP training workshops for Study Coordinators and Data Managers at ANZGOG ASMs.

Corporate Supporters for ANZGOG Research

Support for
 Support for
Support for
Outback and Portec-3




Each year we provide opportunities for leaders in the pharmaceutical and other industries to support the work of the ANZ Gynaecological Oncology Group.  
Sponsorship by these companies allows us to bring outstanding guest speakers from overseas to share and exchange the latest in clinical practice for treatment of gynaecological cancers.  Scientific Sessions, debates and premium Platinum, Gold and Silver sponsorships are also available.
Corporate Sponsors of the 2016 Annual Scientific Meeting
Platinum Sponsor | Roche
At Roche, innovating healthcare is at the core of our business strategy through leading pathology solutions and supporting patient management. Our expanding knowledge and understanding of disease mechanisms leads us to deliver significant benefits to patients and healthcare professionals.
Roche Diagnostics is the world’s leading supplier of in vitro diagnostics (IVD’s). IVD tests – performed in the laboratory or at point of care on blood and other samples from patients – are a critical source of objective information about health and disease. Roche’s diagnostic instruments and reagents help doctors detect diseases, select appropriate treatments and monitor patients’ responses to care.
Visit Roche Website for more information. 
Gold Sponsor | AstraZeneca Australia
AstraZeneca Australia, based in North Ryde, Sydney, is the second largest pharmaceutical company operating in Australia, is one of the country’s largest manufacturers of medicines and is a key exporter to 35 international markets. AstraZeneca produces medicines in a range of therapeutic areas including cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.
AstraZeneca contributes significantly to clinical trials in Australia with approximately 50 concurrent trials in over 300 sites across the country. AstraZeneca’s innovative medicines are used by millions of patients worldwide.
Visit AstraZeneca Website for more information 
If you would like to become an ANZGOG Corporate Supporter, please contact ANZGOG Executive Officer, Alison Evans at or phone  +61 2 8071 4880.